Incidence of oxaliplatin hypersensitivity reaction among colorectal cancer patients: A 5-year retrospective study

Palapinyo, Sirinoot; Klaewsongkram, Jettanong; Sriuranpong, Virote; Areepium, Nutthada.
Pharm. pract. (Granada, Internet) ; 20(2): 1-8, Apr.-jun. 2022. tab
Artículo en Inglés | IBECS (España) | ID: ibc-210411

Documentos relacionados

  1. Meta-analysis of risk factors associated with oxaliplatin hypersensitivity reactions in cancer patients.
  2. Subtyping and prognostic model construction based on vesicle-mediated transport-related genes in colorectal cancer.
  3. Binding Motifs of Carboplatin and Oxaliplatin with Guanine: A Combined MS/MS, IRMPD, and Theoretical Study.
  4. Effect of Severe Renal Dysfunction on the Plasma Levels of DNA-Reactive Platinum after Oxaliplatin Administration.
  5. Efficacy and Safety of Huangqi Guizhi Wuwu Decoction for Oxaliplatin-Induced Peripheral Neurotoxicity: A Systematic Review and Meta-Analysis.
  6. Cancer survivors post-chemotherapy exhibit unimpaired short-latency stretch reflexes in the proximal upper extremity.
  7. Cytokine profiling, pretreatment with anakinra, and tolerance development in platinum-induced mixed hypersensitivity reactions.
  8. Hypersensitivity reactions to platinum-based compounds in the context of pressurized intraperitoneal aerosol chemotherapy (PIPAC): Description and management.
  9. [Three Cases of Febrile Reactions after Using Oxaliplatin].
  10. [A Study of the Safety of Chemotherapy with Generic Oxaliplatin for the Treatment of Colorectal Cancer].